Gene therapies for inherited retinal diseases; OPGx-LCA5 and OPGx-BEST1 in pivotal track; RDH12, MERTK, RHO behind; tied to Foundation Fighting Blindness and RD Fund
No detailed funding rounds available.
Total known funding: